Skip to main content
. 2018 Mar 12;7(1):21–27. doi: 10.1080/21556660.2018.1445092

Table 4.

Description of healthcare resource utilization during the observation period after ceritinib initiation.

Healthcare resource utilization, per patient per six months Ceritinib patients (N = 164)
IP admissions, N (%) 1.1 ± 1.9 [0.0]
 Patients with ≥1 IP admission 76 (46.3%)
IP days, mean ± SD [median] 10.3 ± 26.1 [0.0]
Days with DME services, mean ± SD [median] 1.2 ± 3.4 [0.0]
Days with EC services, mean ± SD [median] 0.8 ± 1.8 [0.0]
Days with OP services, mean ± SD [median] 23.4 ± 14.3 [21.2]
  Home care services 3.4 ± 11.3 [0.0]
  Skilled nursing facility services 0.7 ± 3.0 [0.0]
  Office visits 18.3 ± 10.8 [16.3]
  Ambulatory surgical centre visits 0.1 ± 0.6 [0.0]
  Other OP services 0.9 ± 2.3 [0.0]
 Days with drug administration-related claims 3.7 ± 5.5 [1.7]
 Days with laboratory tests 6.6 ± 5.5 [6.1]

DME: durable medical equipment; EC: emergency care; IP: inpatient; OP: outpatient; SD: standard deviation.